The BioRegion of Catalonia at BIO 2012

The BioRegion of Catalonia at BIO 2012

More information at:
www.biocat.cat/bio2012
CONNECT, PARTNER & INNOVATE WITH
THE BIOREGION
OF CATALONIA
AT BIO 2012
June 18-21, 2012
Booth 437
Boston Convention & Exhibition Center
415 Summer Street • Boston (USA)
With the support of:
10
UNIVERSITIES
(out of 12) offering
studies in life sciences
and two of the 20
top-ranked business
schools in the world
481
COMPANIES
(71 pharmaceutical, 91
biotechnology, 106 innovative
medical technology, 29 fine
chemicals, 45 food, 9 bioinformatics
and the rest provide support
services or are linked to the sector
in some way)
20
SCIENCE AND
TECHNOLOGY
PARKS
433
RESEARCH
GROUPS
working
in life sciences
80
RESEARCH
CENTERS
in life sciences
74
ERC
(European Research
Council) GRANTS
awarded to Catalan
scientists working
in life sciences,
between 2007
and 2011
13
HOSPITALS
with noteworthy
research activity
(out of 214) and
5 research institutes
recognized by
the Spanish
government
BIOCAT, LEADING BIOTECHNOLOGY IN CATALONIA
BOOTH 437
Biocat is the entity that coordinates
and promotes innovation in
biotechnology, biomedicine and
medical technology sector in Catalonia,
following a strategic plan focused on:
Source: Biocat Report 2011 and web Directory
• Consolidating Catalonia's biocluster
• Promoting Business competitiveness
• Fostering Internationalisation
• Training and attracting talent
• Generating a positive social perception
of biotechnology
BIOREGION
OF CATALONIA
MORE THAN 60% OF THE
SPANISH REPRESENTATION
PAVILION
SPAIN
VISIT OUR PAVILION AND MEET THE
KEY PLAYERS OF THE CATALAN
BIOTECHNOLOGY AT BIO:
ANDALUCIA
BIOREGION
BIOBASQUE
CATALONIA
72 COMPANIES AND
SCIENTIFIC INSTITUTIONS
MORE THAN 100 DELEGATES
BOOTH 437
ENTRANCE
ENTRANCE
MASSACHUSETTS
ITALY
PENNSYLVANIA
BIO
GERMANY
ONTARIO
GEORGIA
CANADA
PARTNERING
DESK
BIOMARYLAND
QUEBEC
BUSINESS FORUM
FRANCE
SPAIN
PAVILION
ENTRANCE
ENTRANCE
FLOORPLAN FOR 2012 BIO
BOOTH DISTRIBUTION
COMPANIES
437-31
437-47
437-42
437-38
437-33
437-45
437-37
437-34
437-28
437-23
437-51
437-54
437-41
437-50
437-52
437-36
AB-BIOTICS
AB-THERAPEUTICS
ALTHIA
ANAXOMICS
AROMICS
ARCHIVEL
BCN PEPTIDES
BIOCHEMIZE
BIONURE
GP PHARM
GRIFOLS ENGINEERING
HEXASCREEN CULTURE TECHNOLOGIES
IMMUNNOVATIVE DEVELOPMENTS
INTELLIGENT PHARMA
JANUS DEVELOPMENTS
KYMOS
437-29
437-48
437-44
437-35
437-40
437-30
437-39
437-24
437-49
437-25
437-32
437-43
437-46
437-26
437-53
437-27
LABORATORIOS RUBIÓ
LIFE SCIENCE ENTREPRENEURS
LYKERA BIOMED
NANOTARGETING
NEUROTEC PHARMA
OMNIA MOLECULAR
ORYZON GENOMICS
PALAU PHARMA
PALOBIOFARMA
PLASMIA BIOTECH
READYCELL
RECERCA CLÍNICA
REIG JOFRÉ GROUP
SALVAT
TRIFERMED
VCN BIOSCIENCIES
BIOCAT’S BOOTH
COMPANIES
•
•
•
•
•
•
ADVANCELL
BAKER & MCKENZIE
BIOEMPRÈN
BIOIBÉRICA
BIOKIT
CAIXA CAPITAL RISC
•
•
•
•
•
•
DRACONIS PHARMA
ERA BIOTECH
ESTEVE
GESAWORLD
GRI-CEL
LACER
•
•
•
•
•
•
NATURA BISSÉ INTERNATIONAL
PERFORMLAB
ROUSAUD COSTAS DURAN
SAGETIS BIOTECH
THROMBOTARGETS
YSIOS CAPITAL PARTNERS
INSTITUTIONS
•
•
•
•
•
•
•
•
•
•
•
•
ACC1Ó
BLOOD AND TISSUE BANK (BST)
BARCELONA CITY COUNCIL
BARCELONA SCIENCE PARK
BIOCAT
BIOMEDICAL ENGINEERING RESEARCH
CENTRE (CREB-UPC)
BIONANOMED CATALUNYA NETWORK
BOSCH I GIMPERA FOUNDATION
CATALAN INSTITUTE
OF NANOTECHNOLOGY (ICN)
CENTRE FOR GENOMIC REGULATION (CRG)
CLÍNIC FOUNDATION FOR BIOMEDICAL
RESEARCH
GUTTMANN UNIVERSITARY INSTITUTE FOR
NEUROREHABILITATION
• IMB-CNM NATIONAL MICROELECTRONICS CENTER
(CSIC)
• INSTITUTE OF ADVANCED CHEMISTRY OF
CATALONIA (IQAC-CSIC)
• IRB BARCELONA
• LEITAT TECHNOLOGY CENTER
• ONCOCAT NETWORK
• PARC DE L'ALBA, ALBA SYNCHOTRON
• POMPEU FABRA UNIVERSITY (UPF)
• RESEARCH & TECHNOLOGY INSTITUTE FOR
FOOD & AGRICULTURE (IRTA)
• SECOT
• UNIVERSITAT POLITÈCNICA DE CATALUNYA (UPC)
• UNIVERSITAT POMPEU FABRA (UPF)
C
COMPANIES
437-31
437-47
437
437-42
AB-BIOTICS
AB-THERAPEUTICS
ADVANCELL
ALTHIA
Contact: Miquel A. Bonachera
[email protected]
www.ab-biotics.com
Contact: Carles Domènech
[email protected]
www.ab-therapeutics.com
Contact: Clara Campàs de Moya
[email protected]
www.advancell.net
Contact: Anna Colomer
[email protected]
www.althia.es
437-38
437-45
437-33
437
ANAXOMICS
ARCHIVEL
AROMICS
BAKER&MCKENZIE
Contact: Vesna Radovanovic
[email protected]
www.anaxomics.com
Contact: Olga Rué
[email protected]
www.archivelfarma.com
Contact: Carmen Plasencia
[email protected]
www.aromics.es
Contact: Montserrat Llopart
[email protected]
www.bakermckenzie.com
437-37
437-34
437
437
BCN PEPTIDES
BIOCHEMIZE
BIOEMPRÈN
BIOIBÉRICA
Contact: Jordi Piró
[email protected]
www.bcnpeptides.com
Contact: Jaume Mir
[email protected]
www.biochemize.com
Contact: Jaume Amat
[email protected]
www.bioempren.com
Contact: Josep Vergés
[email protected]
www.bioiberica.com
437
437-28
437
437
BIOKIT
BIONURE
CAIXA CAPITAL RISK
DRACONIS PHARMA
Contact: Pau Bruguera
[email protected]
www.biokit.com
Contact: Albert Zamora
[email protected]
www.bionure.com
Contact: Patricia Burés
[email protected]
www.caixacapitalrisc.es
Contact: Lluis Gomez
[email protected]
www.draconispharma.com
437
437
437
437-23
ERA BIOTECH
ESTEVE
GESAWORLD
GP PHARM
Contact: Miriam Bastida
[email protected]
www.erabiotech.com
Contact: Mark Mayhew
[email protected]
www.esteve.es
Contact: José María Pérez
[email protected]
www.gesaworld.com
Contact: Sandra Sánchez
[email protected]
www.gp-pharm.com
C
COMPANIES
437
437-51
437-54
437-41
GRI-CEL
GRIFOLS ENGINEERING
IMMUNOVATIVE DEVELOPMENTS
Contact: Dirk Buscher
[email protected]
www.grifols.com
Contact: Oriol Argemí
[email protected]
www.grifolsengineering.com
HEXASCREEN CULTURE
TECHNOLOGIES
437-50
437-52
437-36
437-29
INTELLIGENT PHARMA
JANUS DEVELOPMENTS
KYMOS
LABORATORIOS RUBIÓ
Contact: Ismael Tejero
[email protected]
www.intelligentpharma.com
Contact: Marion Chalumeau
[email protected]
www.janusdevelopments.com
Contact: Joan Puig de Dou
[email protected]
www.kymos.es
Contact: Ingrid Chasan
[email protected]
www.laboratoriosrubio.com
437
437-48
437-44
437-35
LACER
LIFE SCIENCE ENTREPRENEURS
LYKERA BIOMED
NANOTARGETING
Contact: Xavier Berthet
[email protected]
www.lacer.es
Contact: François Arcand
[email protected]
www.LifSciE.com
Contact: Francesc Mitjans
[email protected]
www.lykerabiomed.com
Contact: Aurora Conill
[email protected]
www.nanotargeting.eu
437
437-40
437-30
437-39
NATURA BISSE INTERNATIONAL
NEUROTEC PHARMA
OMNIA MOLECULAR
ORYZON GENOMICS
Contact: Joaquin Serra
[email protected]
www.naturabisse.es
Contact: Marco Pugliese
[email protected]
www.neurotec-pharma.com
Contact: Ralph Klingmann
[email protected]
www.omniamol.com
Contact: Emili Torrell
[email protected]
www.oryzon.com
Contact: Javier Amayra
[email protected]
www.hexascreen.com
Contact: Natalia de la Figuera
[email protected]
www.immunovative.com
PRODUCT STATUTS
DEVELOPMENT PIPELINE
ACTIVITY
AB
-B
AB IOTI
-T CS
H
AD ERA
VA PE
AL NCE UTI
TH LL CS
AN IA
AX
AR OM
CH IC
S
AR IVE
OM L
BA ICS
KE
BC R&M
N
P cK
BI EPT EN
OC ID ZIE
H
E
BI EM S
OE IZ
M E
BI PR
OI ÈN
BI BÉR
OK IC
A
BI IT
ON
U
CA RE
IX
DR A CA
AC PI
T
ER ON AL
A IS RIS
BI PH K
ES OT A
TE EC RM
A
GE VE H
SA
W
GP O
-P RL
D
GR HAR
I-C M
GR EL
IFO
HE LS E
XA N
IM SC GIN
M RE EE
R
U E
IN NO N C ING
TE VA UL
T
LL
T
JA IG IVE UR
NU EN D E T
E
E
T
KY S D PH VEL CH
M EV AR OP NO
LA OS ELO MA ME LOG
PM
BO
NT IE
S S
EN
LA RAT
TS
CE OR
R
I
OS
LIF
RU
ES
BI
LIK CIE
Ó
N
ER C
NA A B E EN
N IOM TR
NA OTA ED EPR
EN
TU RG
E
EU
NE RA TIN
RS
UR BIS G
OM OTE SE I
N
NI C P TE
OR A M HAR RN
YZ OL M AT
IO
PA ON ECU A
NA
LA GE LA
L
U
N
R
PA P O
LO HA MI
C
PE BIO RMA S
RF FA
RM
O
PL RM A
AS L
A
RE MIA B
AD B
RE YCE IOT
CE LL EC
H
RE RCA
IG C
L
J
RO OF INI
US RÉ CA
SA AUD GRO
GE C UP
O
SA TIS ST
LV BIO AS
A
TH T TE DU
CH RA
RO
N
TR MB
IFE OT
A
VC RM RG
N ED ET
S
YS BIO
IO SC
S IEN
CE
S
PROFILE OF DELEGATES
HUMAN HEALTH
(DIAGNOSTIC VACCINATIONS)
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
HUMAN HEALTH
(THERAPEUTIC)
COSMETICS
AGROFOOD (AGRICULTURE,
LIVESTOCK FARMING, FOOD
& FORESTRY)
BIOPROCESSES, BIOFUELS,
BIOMATERIALS
ANIMAL HEALTH
AUXILIARY SERVICES
ENVIRONEMENT
LABORATORY EQUIPMENT
BIOCATALYSIS
ACTIVE PHARMACEUTICAL
INGREDIENTS
COMPUTATIONAL
SERVICES
CONSULTANCY*
LAW FIRM
1
* (1) BUSINESS DEVELOPMENT
(2) BIOPHARMACEUTICS ENGINEERING
4
(3) TECHNOLOGY TRANSFER
2
VENTURE CAPITAL
BASIC RESEARCH
PRECLINICAL (IN VITRO
TRIAL)
PRECLINICAL (IN VIVO
TRIAL)
CLINICAL PHASE I, II, & III
CLINICAL PHASE IV (IN
MARKET)
BASIC RESEARCH
PILOT PRODUCT
VALIDATION TRIALS
REQUEST FOR
AUTHORISATION
IN MARKET
(4) PUBLIC HEALTH & HEALTH MANAGEMENT
3
1
Apart from Biocat, there are other institutional representatives coming from universities, science &
technology parks, research & technology centers, support entities, networks and public administration.
COMPANIES' PROFILE
ACTIVITY
80%
72,3%
70%
60%
50%
40%
36,2%
30%
OTHER
AUXILIARY SERVICES
BIOPROCESSES,
BIOFUELS, BIOMATERIALS
AGROFOOD
HUMAN HEALTH
(THERAPEUTICS)
ANIMAL HEALTH
4,3%
HUMAN HEALTH
(DIAGNOSTIC-VACCINATIONS)
0%
12,8%
8,5%
10,6%
6,4%
LAW FIRM/
VENTURE CAPITAL
10,6%
10%
CONSULTANCY
17%
20%
DEVELOPMENT PIPELINE
43%
BASIC RESEARCH
53%
PRECLINICAL (IN VITRO TRIAL)
57%
PRECLINICAL (IN VIVO TRIAL)
32%
CLINICAL PHASE I, II, & III
17%
CLINICAL PHASE IV (IN MARKET)
0%
10%
20%
30%
40%
50%
60%
70%
PRODUCT STATUS
15%
BASIC RESEARCH
17%
PILOT PRODUCT
21%
VALIDATION TRIALS
6%
REQUEST FOR AUTHORISATION
11%
IN MARKET
0%
5%
10%
15%
20%
Some of the companies may fall into more than one category
25%
C
COMPANIES
437-24
437-49
437
437-25
PALAU PHARMA
PALOBIOFARMA
PERFORMALB
PLASMIA BIOTECH
Contact: Ignacio Faus
[email protected]
www.palaupharma.com
Contact: Julio Castro Palomino
[email protected]
www.palobiofarma.com
Contact: Marc Ramis
[email protected]
www.performlab.es
Contact: Esteve Guardia
[email protected]
www.plasmiabiotech.com
437-32
437-46
437
437
READYCELL
REIG JOFRÉ GROUP
ROUSAUD COSTAS DURAN
SAGETIS BIOTECH
Contact: Josep O. Nicolás
[email protected]
www.readycell.com
Contact: Ignacio Vila
[email protected]
www.reigjofre.com
Contact: Ignasi Costas
[email protected]
www.rcdslp.com
Contact: Eduard Diviu
[email protected]
www.sagetis-biotech.com
437-43
437-26
437
437-53
RECERCA CLINICA
SALVAT
THROMBOTARGETS
TRIFERMED
Contact: Lluís Cano
[email protected]
www.recercaclinica.com
Contact: Cristina Viayna
[email protected]
www.salvatbiotech.com
Contact: Ignasi Miquel
[email protected]
www.thrombotargets.com
Contact: Stephanie Reid
[email protected]
www.trifermed.com
437-27
437
VCN BIOSCIENCIES
YSIOS CAPITAL PARTNERS
Contact: Manel Cascalló
[email protected]
www.vcnbiosciences.com
Contact: Raúl Martin
[email protected]
www.ysioscapital.com
I
INSTITUTIONS
437
BIOCAT
Contact: Adela Farré
[email protected]
www.biocat.cat
437
437
437
437
437
ACC1Ó
BANC DE SANG
I TEIXITS (BST)
BARCELONA
CITY COUNCIL
BARCELONA
SCIENCE PARK
Contact: Aurora Masip
[email protected]
www.bst.cat
Contact: Jordi Sacristan
[email protected]
www.bcn.cat/barcelonabusiness
Contact: Jesús Purroy
[email protected]
www.apcb.ub.cat
BIOMEDICAL
ENGINEERING
RESEARCH CENTRE
(CREB-UPC)
437
437
437
437
437
BIOMEMS GROUP
BIOSYSTEMS
BIOENGINEERING
(IMB-CNM, CSIC)
BIONANOMED
CATALUNYA NETWORK
BOSCH I GIMPERA
FOUNDATION
Contact: Inma Íñiguez
[email protected]
www.fbg.ub.edu
CENTRE FOR
GENOMIC
REGULATION (CRG)
Contact: Carlos Lurigados
[email protected]
www.bionanomedcat.org
CATALAN
INSTITUTE
OF NANOTECHNOLOGY
(ICN)
437
437
437
437
437
CLÍNIC FOUNDATION
FOR BIOMEDICAL
RESEARCH
GUTTMANN
UNIVERSITARY
INSTITUTE FOR
NEUROREHABILITATION
INSTITUTE OF
ADVANCED
CHEMISTRY
OF CATALONIA
(IQAC-CSIC)
IRB BARCELONA
LEITAT
TECHNOLOGICAL
CENTER
Contact: Clara Barreneche
[email protected]
www.acc10.com
Contact: Francesc Xavier Muñoz
[email protected]
www.imb-cnm.csic.es
Contact: Yolanda Lizarraga
[email protected]
www.fundacioclinic.org
Contact: Josep M Tormos
[email protected]
www.guttmann.com
Contact: Isabel Masip
[email protected]
www.iqac.csic.es
Contact: Jordi Reverter
[email protected]
www.icn.cat
Contact: Manel González
[email protected]
www.creb.upc.es
Contact: Xavier Rubies
[email protected]
www.crg.eu
Contact: Cristina Horcajada
[email protected]
www.irbbarcelona.org
Contact: Francesc Mitjans
[email protected]
www.leitat.org
437
437
437
437
437
ONCOCAT NETWORK
PARC DE L'ALBA,
ALBA SYNCHOTRON
RESEARCH &
TECHNOLOGY
INSTITUTE FOR FOOD
& AGRICULTURE (IRTA)
UNIVERSITAT
POLITÈCNICA
DE CATALUNYA (UPC)
UNIVERSITAT
POMPEU
FABRA (UPF)
Contact: Oscar Carbo
[email protected]
www.upc.edu
Contact: Melquiades Calzado
[email protected]
www.upf.edu
Contact: Carlos Lurigados
[email protected]
www.oncocat.org
Contact: Guy Molénat
[email protected]
www.cells.es
Contact: Eliecer Lopez
[email protected]
www.irta.es
TUESDAY,
JUNE 19TH
AGENDA
7:30am
CATALONIA RACE 5 KM.
Meeting point: Nine Zero Hotel
Network in casual & healthy environment!
i
SUNDAY,
JUNE 17TH
1:00pm – 6:30pm
International Cancer Cluster
Showcase (satellite event)
Whitehead Institute.
Nine Cambridge Center,
Cambridge, MA 02142
INNOVATIVE ONCOLOGY
PIPELINES PRESENTATION BY:
AB THERAPEUTICS
ONCOCAT NETWORK
ORYZON GENOMICS
i
MORE INFO
EVERY DAY:
COMPANY
PRESENTATIONS
JUNE 20 TH
3:00pm - ORYZON
Patriots Room - 104B
i
MORE INFO
Ask us for the
complete schedule!
MORE INFO
2:00pm – 2:45pm
BREAKOUT SESSION
Room: 254A
Crossing Borders and Boundaries – Emerging Strategies
to Promote International Collaboration
Come learn new approaches from 4 leading
biotech regions: Massachusetts, North Carolina,
Israel and Catalonia
i
MORE INFO
3:30pm – 4:30pm
CLUSTER HOUR: MEET EUROPE’S CLUSTERS
AND THEIR GLOBAL PARTNERS
BioRegion of Catalonia presentation. Organiser: CEBR
Booth 3165 – European Commission
i
MORE INFO
WEDNESDAY,
JUNE 20TH
6:30pm – 7:30pm
PRESENTATION OF CATALONIA INTERNATIONAL
LIFE SCIENCE REPORT – ERNST & YOUNG
i
MORE INFO
7.30pm – 9.30pm
CATALAN NETWORKING EVENT
Boston Common Hotel & Conference Center
40 Trinity Place. Boston, MA 02116
i
MORE INFO
THE CATALAN DELEGATION INVITES YOU TO OUR
BIO 2012 RECEPTION
The event will count on the presence of R. Hon. Mr. Artur Mas,
President of the Catalan Government
Venue: Boston Common Hotel - 40 Trinity Place, Boston, MA
WEDNESDAY, JUNE 20 , 2012
TH
7.30 pm - 9.30 pm
A Mediterranean cocktail and Catalan drinks
will be served during the network event
R.S.V.P.: [email protected]
Organized by:
BOOTH 437
Golden Sponsor:
Why Barcelona?
Because it is the ideal
location for your biobusiness.
Barcelona City Council and Biocat
are proud to introduce you the
“biocapital” of Southern Europe.
With more than 480 companies, 430
research groups on life sciences, 20
science & technology parks, 10
universities and 13 top level hospitals,
Catalonia is the most dynamic
bioregion in the Euro-Mediterranean
area and its capital, Barcelona, the
main biotechnology hub.
WHERE THE GLOBAL BIOTECH INDUSTRY COMES TO PARTNER
7 th Annual International Partnering Conference
MARCH 11–13, 2013
Anunci BES
BARCELONA, SPAIN
www.ebdgroup.com/bes
Producer
Supported by
Regional Host Sponsors
Save
the date and
join us in
Barcelona!
More information at:
www.biocat.cat/bio2012
CONNECT, PARTNER & INNOVATE WITH
THE BIOREGION
OF CATALONIA
AT BIO 2012
June 18-21, 2012
Booth 437
Boston Convention & Exhibition Center
415 Summer Street • Boston (USA)
With the support of: